ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Burden of kidney disease among patients with peritoneal dialysis versus conventional in-centre haemodialysis: A randomised, non-inferiority trial

Fan, Li; Yang, Xiao; Chen, Qinkai; Zhang, Hao; Wang, Jianqin; Chen, Menghua; Peng, Hui; Ni, Zhaohui; Wan, Jianxin; Yang, Hongtao; Li, Yun; Wang, Li; Peng, Ai; Lin, Hongli; Zhang, Jinyuan; Shen, Huaying; Xiong, Fei; He, Yongcheng; Zha, Yan; Xie, Minyan; Jiao, Jundong; Jiang, Gengru; Zheng, Xunhuan; Xiao, Jun; Rong, Rong; Qian, Jiaqi; Yu, Xueqing*广东省人民医院; 南昌大学; 上海交通大学; 兰州大学; 哈尔滨医科大学; 深圳市第二人民医院; 苏州大学; 中山大学; 1
Peritoneal Dialysis International2022-5DOI: 10.1177/08968608221088638
4被引12阅读
引用收藏
分享

摘要

Background: Little is known about the impact of haemodialysis (HD) and peritoneal dialysis (PD) on health-related quality of life (HRQoL). We compared HRQoL between conventional in-centre HD and home-based PD in 1082 newly diagnosed kidney failure patients. @@@ Methods: This was an open-label, randomised, non-inferiority trial of adult patients with a diagnosis of end-stage kidney disease (estimated glomerular filtration rate <= 15 mL/min/1.73 m(2)) requiring maintenance dialysis from 36 sites in China randomised 1:1 to receive PD or conventional in-centre HD. The primary outcome was the 'Burden of Kidney Disease' assessed using the Kidney Disease Quality of Life-Short Form (KDQoL-SF) survey over 48 weeks and the main secondary outcomes were the remaining scales of KDQoL-SF and all-cause mortality. The effect of PD versus HD on the primary outcome was compared by their geometric mean (GM) ratio, and non-inferiority was defined by the lower bound of a one-sided 95% confidence interval (CI) >0.9. @@@ Results: A total of 725 subjects completed the trial per protocol (395 PD and 330 HD, mean age 49.8 (standard deviation (SD) 14.4) years, 41.4% women). For the primary outcome, the mean (SD) change in 'Burden of Kidney Disease' over 48 weeks was 2.61 (1.27) in PD group and 2.58 (1.35) in HD group, and the GM ratio (95% CI) was 1.059 (0.908-1.234), exceeding the limit for non-inferiority. For the secondary outcomes, the PD and HD groups were similar in all scales. There were 17 and 31 deaths in PD and HD groups, respectively. Patients receiving PD had more adverse events, adverse event leading to hospitalisation and serious adverse events compared to those allocated to HD, but adverse events leading to death and discontinuation of the trial were not different between PD and HD. @@@ Conclusions: In this trial, PD may be non-inferior to HD on the 'Burden of Kidney Disease' among Chinese kidney failure patients who are of younger age and have lower comorbidity after 48 weeks' follow-up.

学科与关键词

关键词
End-stage kidney diseasehaemodialysishealth-related quality of lifeperitoneal dialysis
相关
加载中…
  • CLINICAL OUTCOMES OF PERITONEAL DIALYSIS PATIENTS TRANSFERRED FROM HEMODIALYSIS: A MATCHED CASE-CONTROL STUDY
    Zhang Li; Cao Tao; Li Zhibin; Wen Qiong; Lin Jianxiong; Zhang Xiaodan; Guo Qunying; Yang Xiao; Yu Xueqing; Mao Haiping*Peritoneal Dialysis International, 2013, 33(3): 259-266.
  • Propensity-matched comparison of mortality between peritoneal dialysis and hemodialysis in patients with type 2 diabetes
    Liu, Hui; He, Zhiren; Hu, Xiaoxuan; Li, Shaoxue; Wang, Lixin; Zhao, Daixin; Lin, Qizhan; Liu, Xusheng; Lu, Fuhua*; Zhang, Difei*INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54(6): 1373-1381.被引 2
  • Impact of dialysis modality choice on the survival of end-stage renal disease patients with congestive heart failure in southern China: A retrospective cohort study
    He, Zhiren; Liang, Hui; Huang, Jing; Zhang, Defei; Ma, Hongyan; Lin, Junjie; Cai, Youqing; Liu, Tonghuan; Li, Hucai; Qiu, Weizhong; Wang, Lingzheng; Yuan, Fengling; Hou, Haijing; Zhao, Daixin; Liu, Xusheng*; Wang, Lixin*Frontiers in Medicine, 2022, 9: 898650.
查看全部 →

发表信息

论文状态
公开发表
期刊
Peritoneal Dialysis International
发表日期
2022-05
卷期
第 42 卷, 第 3 期
页码
246-258
DOI
10.1177/08968608221088638
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Baxter Healthcare Corporation

作者

  • F

    Fan, Li (第一作者)

    1 · sun yat sen univ

  • Y

    Yang, Xiao

    1 · sun yat sen univ

查看全部 27 位作者收起作者
  • C

    Chen, Qinkai

    1 · nanchang univ

  • Z

    Zhang, Hao

  • W

    Wang, Jianqin

    2 · lanzhou univ

  • C

    Chen, Menghua

    ningxia med univ

  • P

    Peng, Hui

    sun yat sen univ

  • N

    Ni, Zhaohui

    shanghai jiao tong univ

  • W

    Wan, Jianxin

    1 · fujian med univ

  • Y

    Yang, Hongtao

    1 · tianjin univ tradit chinese med

  • L

    Li, Yun

    jiangxi prov peoples hosp

  • W

    Wang, Li

    sichuan acad med sci · sichuan prov peoples hosp

  • P

    Peng, Ai

  • L

    Lin, Hongli

    1 · dalian med univ

  • Z

    Zhang, Jinyuan

    455th hosp chinese peoples liberat army

  • S

    Shen, Huaying

    2 · soochow univ

  • X

    Xiong, Fei

    wuhan 1 hosp

  • H

    He, Yongcheng

    shenzhen 2 peoples hosp

  • Z

    Zha, Yan

    guizhou prov peoples hosp

  • X

    Xie, Minyan

    guangzhou panyu cent hosp

  • J

    Jiao, Jundong

    2 · harbin med univ

  • J

    Jiang, Gengru

    shanghai jiao tong univ

  • Z

    Zheng, Xunhuan

    1 · sun yat sen univ

  • X

    Xiao, Jun

    1 · nanchang univ

  • R

    Rong, Rong

    1 · sun yat sen univ

  • Q

    Qian, Jiaqi

    shanghai jiao tong univ

  • Y

    Yu, Xueqing (通讯)

    2 · guangdong prov peoples hosp · 1 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417